As of 2024-09-10, the Relative Valuation of Antares Pharma Inc (ATRS) is 7.32 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 30.9%.
The range of the Relative Valuation is 5.59 - 9.21 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 16.8x - 27.6x | 22.0x |
| Fair Price | 5.59 - 9.21 | 7.32 |
| Upside | 0.1% - 64.7% | 30.9% |
| Date | P/E |